Biodexa Pharmaceuticals Plc (BDRX)

NASDAQ: BDRX · IEX Real-Time Price · USD

0.810

-0.060 (-6.85%)

At close: Apr 18, 2024, 11:28 AM

0.840

+0.030 (3.77%)

After-hours: Apr 18, 2024, 4:44 PM EDT

Biodexa Pharmaceuticals Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Equivalents	2.84	10.06	7.55	10.93	2.34	13.2	17.61	16.18	30.33	2.39
Cash & Cash Equivalents	2.84	10.06	7.55	10.93	2.34	13.2	17.61	16.18	30.33	2.39
Cash Growth	-71.80%	33.28%	-30.95%	366.41%	-82.26%	-25.01%	8.86%	-46.66%	1170.42%	-
Receivables	1.01	1.03	0.57	3.62	1.79	3.71	2.89	2.88	0.89	1.29
Inventory	0	0	0	0	0	0.94	0.82	0.46	0	0
Other Current Assets	0.85	0.67	1.16	-0.81	1.48	0.73	0.99	0.81	0.42	0.42
Total Current Assets	4.69	11.76	9.28	13.74	5.62	18.58	22.3	20.33	31.63	4.1
Property, Plant & Equipment	0.83	1.15	0.54	2.15	1.98	2.53	2.77	1.98	1.52	0.68
Long-Term Investments	0	0	0	0	0	0	0	0	0	0.01
Goodwill and Intangibles	0.01	0	0	12.38	12.37	27.65	31.17	41.34	13.09	0
Other Long-Term Assets	0	0	0	2.63	0.47	0.47	0.45	0.39	0.43	0.38
Total Long-Term Assets	0.84	1.15	0.54	17.16	14.83	30.64	34.39	43.71	15.04	1.08
Total Assets	5.53	12.91	9.82	30.9	20.44	49.22	56.69	64.04	46.66	5.17
Accounts Payable	1.45	1.09	1.23	4.49	2.1	8	8.41	7.08	2.34	1.05
Current Debt	0.16	0.15	0.2	0.41	0.37	0.36	0.54	0.44	0.49	1.25
Other Current Liabilities	0.29	0.6	1.56	0.76	0	0	0.4	1.57	0	0
Total Current Liabilities	1.9	1.84	2.99	5.67	2.47	8.36	9.35	9.1	2.83	2.3
Long-Term Debt	0.46	0.62	0.06	5.67	0.88	6.19	1.62	1.51	1.49	2.12
Other Long-Term Liabilities	0	0	0.05	0	0.17	0	0	6.55	0.35	0
Total Long-Term Liabilities	0.46	0.62	0.11	5.67	1.05	6.19	1.62	8.06	1.84	2.12
Total Liabilities	2.36	2.46	3.1	11.34	3.52	14.55	10.97	17.15	4.67	4.41
Total Debt	0.62	0.77	0.26	6.08	1.25	6.55	2.16	1.95	1.98	3.37
Debt Growth	-18.54%	194.62%	-95.73%	385.78%	-80.87%	203.34%	10.67%	-1.47%	-41.22%	-
Retained Earnings	-135.34	-127.8	-122.43	-99.84	-89.72	-74.65	-59.11	-39.15	-29.22	-20.4
Comprehensive Income	0	0	0	-0.51	-0.3	2.39	3.62	0.39	-0.01	0.14
Shareholders' Equity	3.16	10.45	6.72	19.56	16.92	34.68	45.72	46.89	41.99	0.76
Net Cash / Debt	2.21	9.29	7.29	4.85	1.09	6.66	15.45	14.23	28.35	-0.98
Net Cash / Debt Growth	-76.19%	27.52%	50.35%	344.18%	-83.61%	-56.91%	8.61%	-49.82%	-	-
Net Cash Per Share	-	-	-	-	-	-	-	-	198.15	-19.09
Working Capital	2.79	9.92	6.29	8.07	3.15	10.22	12.96	11.23	28.8	1.8
Book Value Per Share	256.83	1325.68	1969.82	12786.32	11082.42	28481.63	54648.83	56038.84	117407.16	5923.32

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).